ONO PHARMA USA continues to expand footprint

August 31, 2022 by Chain Drug Review (OPUS) president and CEO, as well as future commercialization opportunities for the upcoming products in the U.S., Kunihiko Ito announces its organization and leadership team expansion to advance its clinical development, licensing activities, ONO PHARMA USA, research alliance Pharmacy

CAMBRIDGE, Mass. —ONO PHARMA USA, (OPUS) president and CEO, Kunihiko Ito announces its organization and leadership team expansion to advance its clinical development, research alliance, licensing activities, as well as future commercialization opportunities for the upcoming products in the U.S. Since April 2021 when OPUS opened its new U.S. headquarters in Cambridge, Mass., OPUS has